Your browser is no longer supported. Please, upgrade your browser.
Settings
EPIX ESSA Pharma Inc. daily Stock Chart
EPIX [NASD]
ESSA Pharma Inc.
Index- P/E- EPS (ttm)-2.12 Insider Own- Shs Outstand5.78M Perf Week-8.00%
Market Cap19.93M Forward P/E- EPS next Y- Insider Trans- Shs Float2.12M Perf Month-3.36%
Income- PEG- EPS next Q- Inst Own- Short Float0.09% Perf Quarter61.97%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.21 Perf Half Y9.52%
Book/sh1.07 P/B3.21 EPS next Y- ROA- Target Price- Perf Year-18.52%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range1.87 - 5.83 Perf YTD64.29%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-37.61% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low94.50% ATR0.20
Employees15 Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)48.06 Volatility8.77% 4.75%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.75 Prev Close3.45
ShortableYes LT Debt/Eq- EarningsDec 17 AMC Payout- Avg Volume9.61K Price3.64
Recom- SMA20-0.47% SMA50-2.91% SMA2008.50% Volume4,634 Change5.42%
Mar-18-19 07:30AM  ESSA Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference CNW Group
Mar-14-19 07:30AM  ESSA Pharma to Attend the 31st Annual ROTH Conference PR Newswire
Feb-11-19 07:30AM  ESSA Pharma Announces Two Abstracts Selected to be Presented at the 2019 Genitourinary Cancers Symposium CNW Group
Feb-07-19 05:05PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2018 PR Newswire
Dec-13-18 05:02PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2018 PR Newswire
Nov-14-18 07:35AM  Investor Expectations to Drive Momentum within Townsquare Media, Koss, ESSA Pharma, MVC Capital, Valeritas, and Sonic Foundry Discovering Underlying Factors of Influence GlobeNewswire
Oct-22-18 07:00AM  ESSA Appoints Otello Stampacchia, PH.D., of Omega Funds to Board of Directors PR Newswire
Aug-29-18 07:00AM  ESSA Pharma to Present at 20th Annual Global Investment Conference In New York City September 4 - 6, 2018 PR Newswire
Aug-14-18 07:00AM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2018 CNW Group
May-14-18 07:15PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2018 CNW Group -5.16%
May-10-18 05:05PM  Essa Pharma Inc. Regains Compliance with NASDAQ Listing Requirements CNW Group
Apr-26-18 07:00AM  ESSA to present at Bloom Burton & Co. Healthcare Investor Conference 2018 CNW Group
Apr-25-18 07:00AM  ESSA Pharma Inc. Announces Completion of Share Consolidation CNW Group
Apr-24-18 07:30AM  ESSA Pharma Enhances R&D Capabilities with Two New Key Hires CNW Group +8.12%
Apr-19-18 07:38PM  ESSA Pharma Inc. Announces Share Consolidation CNW Group +5.69%
Apr-12-18 09:51AM  Does ESSA Pharma Inc (CVE:EPI) Go Up With The Market? Simply Wall St.
Mar-28-18 09:56PM  ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders PR Newswire
Feb-23-18 09:02AM  ESSA Pharma Approves Stock Option Plan, RSU Plan, and Option Grants PR Newswire
09:02AM  ESSA Pharma Approves Stock Option Plan, RSU Plan, and Option Grants CNW Group
Feb-13-18 05:00PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017 PR Newswire
05:00PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017 CNW Group
Jan-26-18 07:00AM  ESSA to Present at Noble Capital Markets' NobleCon14 PR Newswire
07:00AM  ESSA to Present at Noble Capital Markets' NobleCon14 CNW Group
Jan-25-18 11:00PM  ESSA Announces Management Team Change PR Newswire -6.33%
11:00PM  ESSA Announces Management Team Change CNW Group
Jan-16-18 09:40PM  ESSA expects 180-day extension to regain compliance with the Nasdaq Bid Price Rule CNW Group
08:40AM  ESSA Completes Second Tranche of Equity Offering, Raising Additional US$5 Million PR Newswire
Jan-09-18 08:43AM  ESSA Completes US$21 Million Equity Offering PR Newswire -9.72%
08:40AM  ESSA Completes US$21 Million Equity Offering CNW Group
Jan-05-18 06:30PM  ESSA Announces Filing of Second Amended and Restated Prospectus Supplement and an Update to Previously Announced Equity Offering PR Newswire +8.42%
06:30PM  ESSA announces filing of second amended and restated prospectus supplement and an update to previously announced equity offering CNW Group
Jan-02-18 07:45PM  ESSA Announces Filing of Amended and Restated Prospectus Supplement and an Update to Previously Announced Equity Offering CNW Group +8.53%
Dec-19-17 07:40AM  Wired News ESSA Announces Update on Previously Declared Equity Offering and Filing of Prospectus Supplement ACCESSWIRE -8.31%
Dec-15-17 10:52PM  ESSA Announces Filing of Prospectus Supplement and an Update to Previously Announced Equity Offering PR Newswire
10:42PM  ESSA Announces Filing of Prospectus Supplement and an Update to Previously Announced Equity Offering CNW Group
Dec-13-17 08:55AM  ESSA Pharma Announces Pricing of Previously Announced Equity Offering CNW Group
Dec-12-17 05:35PM  ESSA Pharma Announces Overnight Marketed Equity Offering CNW Group
Dec-11-17 09:21PM  ESSA Pharma Announces Financial Results for the Fiscal Fourth Quarter and Year Ended September 30, 2017 PR Newswire -8.97%
Nov-22-17 05:05PM  ESSA Pharma Announces New Listing on the TSX Venture Exchange Concurrent with Voluntary Delisting from the TSX PR Newswire
Sep-11-17 07:30AM  ESSA Pharma Announces Results from the Phase 1 Clinical Trial of EPI-506 for Treatment of mCRPC and Updates Clinical and Strategic Plans PR Newswire -36.61%
07:30AM  ESSA Pharma Announces Results from the Phase 1 Clinical Trial of EPI-506 for Treatment of mCRPC and Updates Clinical and Strategic Plans CNW Group
Sep-07-17 07:30AM  ESSA Pharma Announces Abstract Presentation on EPI-506 at the European Society for Medical Oncology 2017 Congress PR Newswire +37.50%
07:30AM  ESSA Pharma Announces Abstract Presentation on EPI-506 at the European Society for Medical Oncology 2017 Congress CNW Group
Sep-01-17 07:30AM  ESSA Pharma to Present at Rodman & Renshaw 19th Annual Global Investment Conference CNW Group
Aug-14-17 08:55PM  ESSA Pharma Provides Business Update and Announces Financial Results for the Fiscal Third Quarter Ended June 30, 2017 CNW Group
Jul-24-17 07:30AM  ESSA Pharma Provides Further Update on Proposed Equity Offering PR Newswire +41.71%
07:30AM  ESSA Pharma Provides Further Update on Proposed Equity Offering CNW Group
Jul-21-17 07:30AM  ESSA Pharma Announces Receipt of NASDAQ Notice of Market Value Deficiency CNW Group +24.20%
Jul-20-17 07:30AM  ESSA Pharma Announces Receipt of NASDAQ Notice of Bid Price Deficiency CNW Group -16.64%
Jul-18-17 08:07AM  ESSA Pharma Announces Update to Proposed Equity Offering PR Newswire
Jul-13-17 11:57AM  ESSA Pharma Announces Pricing of Proposed Equity Offering PR Newswire -28.00%
11:57AM  ESSA Pharma Announces Pricing Of Proposed Equity Offering CNW Group
Jul-12-17 04:10PM  ESSA Pharma Announces Overnight Marketed Equity Offering CNW Group
ESSA Pharma Inc., a pharmaceutical company, focuses on the development of small molecule drugs for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.